Blue Trust’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
Blue Trust's ACLS Position: Q3 2026 in Review
Blue Trust increased its Axcelis (ACLS) stake by 133% in Q3 2026, buying an estimated $512 and bringing the position to 7 shares worth $918. The position accounts for ﹤0.01% of the portfolio, ranked #2183.
Blue Trust first reported a position in ACLS in Q2 2022 and has held it in 18 quarters since. The position peaked at $50K in Q4 2023. 313 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.
- Blue Trust held 7 shares of Axcelis worth $918 as of Q3 2026.
- Blue Trust bought 4 Axcelis shares in Q3 2026, an estimated $512.
- Axcelis made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2183 holding.
- Blue Trust first reported a position in Axcelis in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Axcelis position peaked at $50K in Q4 2023.
- 313 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.